Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18233537 | 0.85 | HRH3 (0.41) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 | |
| SCHEMBL2380517 | 0.83 | HRH3 (0.50) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 | |
| SCHEMBL2619346 | 0.83 | HRH3 (0.59) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 | |
| SCHEMBL28975569 | 0.81 | HRH3 (0.44) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 | |
| SCHEMBL487617 | 0.81 | HRH3 (0.55) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 | |
| SCHEMBL30398570 | 0.81 | HRH3 (0.55) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 | |
| SCHEMBL2619348 | 0.80 | HRH3 (0.56) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 | |
| SCHEMBL11860121 | 0.80 | HRH3 (0.56) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 | |
| SCHEMBL3840575 | 0.80 | HRH3 (0.56) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 | |
| SCHEMBL22404255 | 0.80 | HRH3 (0.56) | HRH3CYP1A2CYP2D6KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4314945-B1 | ELECTROCHROMIC ELEMENT, ELECTROCHROMIC DISPLAY DEVICE, ELECTROCHROMIC LIGHT-CONTROLLING DEVICE, AND ELECTROLYTE COMPOSITION | RICOH CO LTD (JP) | 2025-12-17 | — | — | EP | claimed |
| CN-119798143-A | Synthesis method of 5-ethyl-2-pyridine ethanol | 安徽尖峰北卡药业有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-116496207-A | Method for green synthesis of 4- [2- (5-ethyl-2-pyridyl) ethoxy ] benzaldehyde | 上海北卡医药技术有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-108484488-B | Method for synthesizing 4- [2- (5-ethyl-2-pyridyl) ethoxy ] benzaldehyde by photo/nickel concerted catalysis | 陕西师范大学 | 2021-06-08 | — | — | CN | claimed |
| CN-108484488-A | A kind of method of light/nickel concerted catalysis synthesis 4- [2- (5- ethyl -2- pyridyl groups) ethyoxyl] benzaldehyde | 陕西师范大学 | 2018-09-04 | — | — | CN | claimed |
| EP-2310367-A1 | A PROCESS FOR THE PREPARATION OF 4-Ý2-(5-ETHYL-2-PYRIDYL)ETHOXY¨NITROBENZENE AND PIOGLITAZONE | ERREGIERRE S.p.A. (IT) | 2011-04-20 | — | — | EP | claimed |
| US-20110046382-A1 | PROCESS FOR THE PREPARATION OF 4-[2-(5-ETHYL-2-PYRIDYL)ETHOXY]NITROBENZENE AND PIOGLITAZONE | ERREGIERRE S.P.A. (IT) | 2011-02-24 | — | — | US | claimed |
| WO-2009133576-A1 | A PROCESS FOR THE PREPARATION OF 4-[2-(5-ETHYL-2-PYRIDYL)ETHOXY]NITROBENZENE AND PIOGLITAZONE | ERREGIERRE S.P.A. (IT) | 2009-11-05 | — | — | WO | claimed |
| US-20090118514-A1 | PROCESSES FOR PREPARING PIOGLITAZONE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | DR. REDDY'S LABORATORIES, INC. | 2009-05-07 | — | — | US | claimed |
| WO-2004108721-A1 | PROCESS FOR THE PREPARATION OF 5-[[4-[2-(5-ETHYL-2-PYRIDINYL)ETHOXY]PHENYL] METHYL]-2,4-THIAZOLIDINEDIONE | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2004-12-16 | — | — | WO | claimed |
| EP-4314945-B1 | ELECTROCHROMIC ELEMENT, ELECTROCHROMIC DISPLAY DEVICE, ELECTROCHROMIC LIGHT-CONTROLLING DEVICE, AND ELECTROLYTE COMPOSITION | RICOH CO LTD (JP) | 2025-12-17 | — | — | EP | disclosed |
| CN-120463701-B | Method for continuously preparing pioglitazone intermediate through microtubules | 浙江大学 | 2025-09-12 | — | — | CN | disclosed |
| CN-120463701-A | Method for continuously preparing pioglitazone intermediate through microtubules | 浙江大学 | 2025-08-12 | — | — | CN | disclosed |
| CN-119798143-A | Synthesis method of 5-ethyl-2-pyridine ethanol | 安徽尖峰北卡药业有限公司 | 2025-04-11 | — | — | CN | disclosed |
| US-20240184178-A1 | ELECTROCHROMIC ELEMENT, ELECTROCHROMIC DISPLAY DEVICE, ELECTROCHROMIC LIGHT-CONTROLLING DEVICE, AND ELECTROLYTE COMPOSITION | RICOH COMPANY, LTD. (JP) | 2024-06-06 | — | — | US | disclosed |
| US-4812570-A | Method for producing thiazolidinedione derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-03-14 | — | — | US | disclosed |
| EP-0257781-A1 | A method for producing thiazolidinedione derivatives | Takeda Chemical Industries, Ltd. (JP) | 1988-03-02 | — | — | EP | disclosed |
| US-4687777-A | pioglitazone and salts | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-08-18 | — | — | US | disclosed |
| EP-0193256-A1 | Thiazolidinedione derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1986-09-03 | — | — | EP | disclosed |
| US-4006127-A | Cationic diazacyanine dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118514-A1 | PROCESSES FOR PREPARING PIOGLITAZONE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | DPP4, SLC5A2, SLC5A1 | HRH3 2830/4885CYP1A2 671/4885CYP2D6 127/4885 |
| US-20110046382-A1 | PROCESS FOR THE PREPARATION OF 4-[2-(5-ETHYL-2-PYRIDYL)ETHOXY]NITROBENZENE AND PIOGLITAZONE | HNF4A, PPARA, CYP2E1 | HRH3 3227/4885CYP1A2 107/4885CYP2D6 591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.